Innate Pharma (IPHA) EPS (Basic) (2019 - 2025)
Innate Pharma (IPHA) posted quarterly EPS (Basic) of -$0.28 for Q2 2025, up 19.82% year-on-year from -$0.23 in Q2 2024, and up 59.78% on a QoQ basis from -$0.69 in Q4 2024.
Innate Pharma (IPHA) EPS (Basic) (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has reported EPS (Basic) for 7 consecutive years, with -$0.28 the latest figure, recorded in Q2 2025.
- Quarterly EPS (Basic) rose 19.82% year-over-year to -$0.28 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$1.21 (down 2.77% YoY) and the FY2025 annual result came in at -$0.28, down 322.27% from the prior year.
- EPS (Basic) advanced to -$0.28 in Q2 2025 per IPHA's latest filing, from -$0.69 in the prior quarter.
- Over the last five years, EPS (Basic) for IPHA reached as high as $1.54 in Q4 2021 and fell as low as -$0.69 in Q4 2024.
- A 5-year average of $0.06 and a median of -$0.11 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) jumped 268.82% — and 2023, when it sank 3069.28%.
- Year by year, EPS (Basic) stood at $1.54 in 2021, then slumped by 49.66% to $0.77 in 2022, then sank by 113.84% to -$0.11 in 2023, then sank by 548.69% to -$0.69 in 2024, then soared by 59.78% to -$0.28 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.28, -$0.69, and -$0.35 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.28 |
| Dec 31, 2024 | -0.69 |
| Jun 30, 2024 | -0.35 |
| Dec 31, 2023 | -0.11 |
| Jun 30, 2023 | -0.03 |
| Dec 31, 2022 | 0.77 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2021 | 1.54 |
| Jun 30, 2021 | -0.34 |
| Dec 31, 2020 | -0.91 |
| Jun 30, 2020 | -0.15 |
| Dec 31, 2019 | -0.35 |